Equity
€120,342 ▲ 12.1%
RINF MEDICA has made a profit without a break since 2022.
RINF MEDICA
Lifetime
19 annual accounts with figures on one time axispeak €44,439 (2024)
€33,073▼ 25.6%
lowest -€5,170 (2008)
€12,990▲ 102%
peak €120,342 (2025)
€120,342▲ 12.1%
€38,795▼ 3.2%
Board1 name since 2024
1 directorJean Claude RWAKA GAHONZIRE
Documentsfilings and deeds
13-07-202618 days before the deadline
2025abbreviated format
Gross margin from €44,439 to €33,073Result from €6,427 to €12,990Equity from €107,352 to €120,342Cash from €56,188 to €80,953
Key points
from the 2025 annual accountsChecked score
94
Excellent
Financially stronger than 76% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.7%
01-2025: 0.7%● unchanged vs 12-2024
02-2025: 0.7%● unchanged vs 01-2025
03-2025: 0.7%● unchanged vs 02-2025
04-2025: 0.7%● unchanged vs 03-2025
05-2025: 0.7%● unchanged vs 04-2025
06-2025: 0.7%● unchanged vs 05-2025
07-2025: 0.7%● unchanged vs 06-2025
08-2025: 0.9%▲ +0.2 percentage points vs 07-2025
09-2025: 1.0%▲ +0.1 percentage points vs 08-2025highest value
10-2025: 0.7%▼ -0.3 percentage points vs 09-2025
11-2025: 0.7%● unchanged vs 10-2025
12-2025: 0.7%● unchanged vs 11-2025
01-2026: 0.7%● unchanged vs 12-2025
02-2026: 0.7%● unchanged vs 01-2026
03-2026: 0.7%● unchanged vs 02-2026
04-2026: 0.8%▲ +0.1 percentage points vs 03-2026
05-2026: 0.7%▼ -0.1 percentage points vs 04-2026
06-2026: 0.7%● unchanged vs 05-2026
07-2026: 0.7%● unchanged vs 06-2026
08-2026: 0.2%▼ -0.5 percentage points vs 07-2026lowest value
09-2026: 0.2%● unchanged vs 08-2026lowest value
10-2026: 0.2%● unchanged vs 09-2026lowest value
11-2026: 0.2%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
1 of the last 3 accounts late
No main activity registered
lowers risk
Size: total assets €159,137
Liquidity: current ratio 6.87, cash €80,953
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 89% on liquidity, 62% on profitability and 70% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as RINF MEDICA has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of RINF MEDICA itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for RINF MEDICA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.87 (7.89 in 2024), above the usual 1.5. Short-term debt is 12.3% and cash 50.9% of total assets. 24.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
18 days early
2024
29 days late
2023
56 days late
2022
31 days late
2021
23 days late
2020
91 days late
2019
98 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 44 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0889320150
Change of role: Jean Claude RWAKA GAHONZIRE, from manager to director
Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 27-12-2023 · Gazette deed
Incorporation
published on 18-05-2007 · Gazette deed
Official details
Source: KBO- Status
- Active since 09-05-2007Normal situation
- Activity
- “Soins infirmiers (notamment soins de santé, palliatifs, toilettages, pratiques d'injections, application de pansements, prises…” (deed in French)From the articles, 11 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Annual accounts 2025
- €159,137▲ 7.9%
- Filing
- Filed on 13-07-2026, 18 days before the end of the filing period
Insights on RINF MEDICA
RINF MEDICA files the abbreviated format. That format states no turnover. The gross margin rose from €6,789 in 2007 to €33,073 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about RINF MEDICA
- What is the company number of RINF MEDICA?
- The company number of RINF MEDICA is 0889.320.150. The VAT number is the same number with BE in front: BE 0889.320.150.
- Where is RINF MEDICA based?
- The registered office is at Avenue des Jonquilles 31, 1480 Tubize.Company details
- What is the legal form of RINF MEDICA?
- RINF MEDICA is a private limited company (BV).
- When was RINF MEDICA founded?
- RINF MEDICA was founded on 09-05-2007.
- Is RINF MEDICA still active?
- Yes, RINF MEDICA is an active enterprise in the KBO register.
- What is the turnover of RINF MEDICA?
- The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €33,073 and 1,231 comparable companies of the same size. It probably lies between €63,000 and €220,000. It is a rough estimate. In financial year 2023 turnover was €60,011.Financials
- Is RINF MEDICA profitable?
- In financial year 2025, RINF MEDICA made a profit of €12,990.
- Where can I find the annual accounts of RINF MEDICA?
- RINF MEDICA filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of RINF MEDICA due?
- RINF MEDICA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.